Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition comprising rilmenidine compound as active ingredient for treatment of fragile X syndrome or related developmental disability

Composition comprising rilmenidine compound as active ingredient for treatment of fragile X syndrome or related developmental disability

US Patent 12396983 · Granted Aug 26, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Marker for diagnosing atherosclerosis severity, and diagnostic method using same2025
Method and device for mutation prioritization for personalized therapy2020
Method and device for generating pileup file from compressed genomic data2019
Methods and systems for customizable clustering of sub-networks for bioinformati2017
Bandwidth calculating method and apparatus for resource reservation in mVoIP sys2017
Method, medium, and system for encrypting and/or decrypting information of micro2014